Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00925834
Other study ID # SUGOKO
Secondary ID
Status Completed
Phase N/A
First received June 19, 2009
Last updated June 19, 2009
Start date July 2008
Est. completion date August 2008

Study information

Verified date June 2009
Source Technische Universität München
Contact n/a
Is FDA regulated No
Health authority Germany: Ethics Commission
Study type Interventional

Clinical Trial Summary

The aim of this randomized controlled pilot study was to answer the following questions:

1. Is it possible to affect the diameter of coronary arteries through a placebo injection, which is administered intracoronarily together with a standardized verbal suggestion of coronary vasodilation?

2. Is it possible to affect the diameter of coronary arteries through a pharmacologically underdosed nitroglycerine injection, which is administered intracoronarily together with a standardized verbal suggestion of coronary vasodilation?


Description:

The present study is a randomized controlled double-blind single center study in order to investigate the effects of verbal suggestions ('vasodilatation') in combination with either a placebo-intervention (sodium chloride 0.9%) or an underdosed vasodilating medication (nitroglycerine) on the diameter of coronary arteries. 60 patients with a clinical indication to undergo a coronary angiogram were recruited in the German Heart Centre Munich. Patients with acute myocardial events and the necessity for coronary intervention were excluded from the study. Patients were randomized into one of four arms of the two experiments:

Experiment A: Intracoronary (i.c.) placebo-infusion together with a standardized verbal suggestion of coronary vasodilation vs. i.c. placebo-infusion without verbal suggestion.

Experiment B: i.c. infusion of a very low dosed nitroglycerin together with a standardized verbal suggestion of coronary vasodilation vs. i.c. nitroglycerine infusion without verbal suggestion.

To our best knowledge this study is the first to investigate the modulating effects of verbal suggestions going along with medical interventions on the diameter of coronary arteries during heart catheterization.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date August 2008
Est. primary completion date August 2008
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- medical indication for heart catheterization

- written informed consent

Exclusion Criteria:

- acute myocardial infarction

- acute elevation of cardiac enzymes

- regular intake of drugs containing nitroglycerin

- intolerance of nitroglycerin

- hypotension

- renal insufficiency

- diabetes mellitus

- hyperthyroidism

- pregnancy

- acute psychiatric disease

- cognitive impairment

- prinzmetal's angina

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Basic Science


Related Conditions & MeSH terms


Intervention

Behavioral:
Verbal suggestions
Verbal suggestions of a vasodilatory effect on cardiac vessels

Locations

Country Name City State
Germany Department of Psychosomatic Medicine, Technische Universität München Munich

Sponsors (3)

Lead Sponsor Collaborator
Technische Universität München German Heart Center, Ludwig-Maximilians - University of Munich

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Stenosis Diameter (Quantitative Coronary Analysis) 60 sec after intervention No
Secondary Heart rate immediately before and after intervention No
Secondary Systolic blood pressure immediately before and after intervention No
Secondary Diastolic blood pressure immediately before and after intervention No
Secondary Chest Pain immediately before and after intervention No
Secondary Subjective distress immediately before and after intervention No
See also
  Status Clinical Trial Phase
Completed NCT03193294 - CORonary MICrovascular Angina (CorMicA) N/A
Recruiting NCT03033810 - FFR Versus iFR in Assessment of Hemodynamic Lesion Significance N/A
Recruiting NCT04575207 - The Flash FFR Ⅱ Study N/A
Active, not recruiting NCT03656848 - The FAVOR III China Study N/A
Completed NCT03067844 - Vascular Effects of Alirocumab in Acute MI-Patients Phase 3